Syngene's (SYNG) Q3FY17 revenue (up 18% YoY) was in line with estimates, aided by sales return.EBITDA margin was inline at 34%, impacted by higher staff costs on account of senior hiring. We believe the recent fire at a facility in Dec'16 could affect capacity for future growth (as it would take..